14. When to take an early FDA meeting, with Aleese Hopkins and Samira Shirwa

Update: 2024-05-21

Description

For smoother sailing with an IND, it can help to have a meeting with the FDA before the IND. But how do you do that and what do you need? Find out from Aleese Hopkins and Samira Shirwa.

Comments

In Channel

15 Navigating CMC and Nonclinical Challenges with Novel Cell and Gene Therapy Products

2025-05-0624:56

14. When to take an early FDA meeting, with Aleese Hopkins and Samira Shirwa

2024-05-2116:07

13. Getting Out of Trouble, with Chris Vessely

2024-04-1618:10

12. Cybersecurity for Medical Devices, With Becky Ditty and DonnaBea Tillman

2023-11-1427:28

11. eCTD 4.0 and standardized data, with Ben Wimmer

2023-07-1818:55

10. Commercial Readiness, with Vince Narbut

2023-06-2015:35

9. Weight of Evidence vs Carcinogenicity Testing Part 2, with Bruce Pearce

2023-05-1627:36

8. Weight of Evidence vs Carcinogenicity Testing Part 1, with Bruce Pearce

2023-04-1818:14

7. Institutional Memory, with Kerin Ablashi

2023-03-2118:12

6. Potency Assays, with Diana Colleluori

2023-02-2124:07

5. When you should hire a consultant, with HeeSun Smaldore

2023-01-3115:53

4. Assembling Your Non-Clinical IND, with Emily Noonan Place

2023-01-1015:22

3. Gap analysis, with David Pepperl

2022-12-1321:19

2. In vivo cell therapy, with Robert Kutner

2022-11-2220:44

1. What a consultant can do for you, with Debra Barngrover

2022-11-0113:20

Insight at Biologics - Trailer

2022-10-2400:15

00:00

14. When to take an early FDA meeting, with Aleese Hopkins and Samira Shirwa

#box-pro-ellipsis-176568124580839{-webkit-line-clamp:2;}14. When to take an early FDA meeting, with Aleese Hopkins and Samira Shirwa

14. When to take an early FDA meeting, with Aleese Hopkins and Samira Shirwa

biologicsconsulting

14. When to take an early FDA meeting, with Aleese Hopkins and Samira Shirwa